{"id":"https://openalex.org/W4416638185","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4085","title":"Late Breaking Abstract - Results from a phase 1, randomized, double-blind, single and multiple ascending oral dose study characterizing the PK, safety, and target engagement of the Rho kinase 1 and 2 inhibitor ROC-101 in healthy volunteers","display_name":"Late Breaking Abstract - Results from a phase 1, randomized, double-blind, single and multiple ascending oral dose study characterizing the PK, safety, and target engagement of the Rho kinase 1 and 2 inhibitor ROC-101 in healthy volunteers","publication_year":2025,"publication_date":"2025-09-27","ids":{"openalex":"https://openalex.org/W4416638185","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4085"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2025.pa4085","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4085","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa4085","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary hypertension","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082059107","display_name":"Marc J.C. Humbert","orcid":"https://orcid.org/0000-0003-0703-2892","observed_orcids":["https://orcid.org/0000-0003-0703-2892"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210162942","display_name":"Bic\u00eatre Hospital","ror":"https://ror.org/05c9p1x46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210162942","https://openalex.org/I4405259118"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marc Humbert","raw_affiliation_strings":["1Universit\u00e9 Paris-Saclay, Inserm U999, H\u00f4pital Bic\u00eatre, Assistance Publique H\u00f4pitaux de Paris, Le Kremlin-Bic\u00eatre, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Universit\u00e9 Paris-Saclay, Inserm U999, H\u00f4pital Bic\u00eatre, Assistance Publique H\u00f4pitaux de Paris, Le Kremlin-Bic\u00eatre, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I4210097159","https://openalex.org/I4210162942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020927659","display_name":"Serra E. Elliott","orcid":"https://orcid.org/0000-0003-4808-7814","observed_orcids":["https://orcid.org/0000-0003-4808-7814"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Serra Elliott","raw_affiliation_strings":["2AllRock Bio, Apex, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AllRock Bio, Apex, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015216742","display_name":"William Marshall","orcid":"https://orcid.org/0000-0002-3520-4500","observed_orcids":["https://orcid.org/0000-0002-3520-4500"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Marshall","raw_affiliation_strings":["3AllRock Bio, Natick, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3AllRock Bio, Natick, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003098375","display_name":"Tanuj K Kamineni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tanuj Kamineni","raw_affiliation_strings":["3AllRock Bio, Natick, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3AllRock Bio, Natick, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104049941","display_name":"Manfred Steiner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Kathryn Steiner","raw_affiliation_strings":["3AllRock Bio, Natick, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3AllRock Bio, Natick, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000391786","display_name":"Valvanera Vozmediano","orcid":"https://orcid.org/0000-0002-2636-1889","observed_orcids":["https://orcid.org/0000-0002-2636-1889"]},"institutions":[{"id":"https://openalex.org/I4210100280","display_name":"Clinical Trial and Consulting","ror":"https://ror.org/00jyb5v21","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100280"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Valvanera Vozmediano","raw_affiliation_strings":["4Clinical Trial & Consulting Services (CTI), Covington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Clinical Trial & Consulting Services (CTI), Covington, United States","institution_ids":["https://openalex.org/I4210100280"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082604779","display_name":"Leyanis Rodr\u00edguez\u2010Vera","orcid":"https://orcid.org/0000-0003-1688-7008","observed_orcids":["https://orcid.org/0000-0003-1688-7008"]},"institutions":[{"id":"https://openalex.org/I4210100280","display_name":"Clinical Trial and Consulting","ror":"https://ror.org/00jyb5v21","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100280"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leyanis Rodriguez-Vera","raw_affiliation_strings":["4Clinical Trial & Consulting Services (CTI), Covington, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Clinical Trial & Consulting Services (CTI), Covington, United States","institution_ids":["https://openalex.org/I4210100280"]}]},{"author_position":"last","author":{"id":null,"display_name":"James Hui","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James Hui","raw_affiliation_strings":["2AllRock Bio, Apex, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AllRock Bio, Apex, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA4085","last_page":"PA4085"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10728","display_name":"Pulmonary Hypertension Research and Treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rho-kinase-inhibitor","display_name":"ROCK inhibitor","score":0.8849999904632568},{"id":"https://openalex.org/keywords/pulmonary-arterial-hypertension","display_name":"pulmonary arterial hypertension","score":0.9679999947547913},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9390000104904175},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.6579999923706055},{"id":"https://openalex.org/keywords/target-engagement","display_name":"target engagement","score":0.8130000233650208},{"id":"https://openalex.org/keywords/fasudil","display_name":"fasudil","score":0.8569999933242798},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8690000176429749},{"id":"https://openalex.org/keywords/qtcf","display_name":"QTcF","score":0.5839999914169312},{"id":"https://openalex.org/keywords/first-in-human-safety","display_name":"first-in-human safety","score":0.5479999780654907},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8955000042915344},{"id":"https://openalex.org/C2776048814","wikidata":"https://www.wikidata.org/wiki/Q5437132","display_name":"Fasudil","level":4,"score":0.8421000242233276},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5990999937057495},{"id":"https://openalex.org/C2781112942","wikidata":"https://www.wikidata.org/wiki/Q178436","display_name":"Constipation","level":2,"score":0.5673999786376953},{"id":"https://openalex.org/C2778609687","wikidata":"https://www.wikidata.org/wiki/Q18390224","display_name":"Rho kinase inhibitor","level":4,"score":0.4916999936103821},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.4334999918937683},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.42500001192092896},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.42340001463890076},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.3970000147819519},{"id":"https://openalex.org/C2780930700","wikidata":"https://www.wikidata.org/wiki/Q1128595","display_name":"Pulmonary hypertension","level":2,"score":0.3813000023365021},{"id":"https://openalex.org/C125287762","wikidata":"https://www.wikidata.org/wiki/Q1758948","display_name":"Absorption (acoustics)","level":2,"score":0.365200012922287},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36320000886917114},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3443000018596649},{"id":"https://openalex.org/C2780940725","wikidata":"https://www.wikidata.org/wiki/Q206280","display_name":"Pulmonary artery","level":2,"score":0.33410000801086426},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.33070001006126404},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.32919999957084656},{"id":"https://openalex.org/C195794163","wikidata":"https://www.wikidata.org/wiki/Q420877","display_name":"Protein kinase C","level":3,"score":0.3215999901294708},{"id":"https://openalex.org/C201800478","wikidata":"https://www.wikidata.org/wiki/Q24721770","display_name":"Rho-associated protein kinase","level":3,"score":0.31299999356269836},{"id":"https://openalex.org/C2778506911","wikidata":"https://www.wikidata.org/wiki/Q2849606","display_name":"Vasospasm","level":3,"score":0.3122999966144562},{"id":"https://openalex.org/C2779319286","wikidata":"https://www.wikidata.org/wiki/Q415744","display_name":"Riluzole","level":4,"score":0.3059999942779541},{"id":"https://openalex.org/C2777543607","wikidata":"https://www.wikidata.org/wiki/Q1153419","display_name":"Interstitial lung disease","level":3,"score":0.3034000098705292},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.2953999936580658},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.27970001101493835},{"id":"https://openalex.org/C172268261","wikidata":"https://www.wikidata.org/wiki/Q4764988","display_name":"Animal studies","level":2,"score":0.27869999408721924},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.2768000066280365},{"id":"https://openalex.org/C160145004","wikidata":"https://www.wikidata.org/wiki/Q413209","display_name":"TRPV1","level":4,"score":0.2662000060081482},{"id":"https://openalex.org/C2779961880","wikidata":"https://www.wikidata.org/wiki/Q1067506","display_name":"Vasoconstriction","level":2,"score":0.26339998841285706},{"id":"https://openalex.org/C534529494","wikidata":"https://www.wikidata.org/wiki/Q7891","display_name":"Respiratory system","level":2,"score":0.2572999894618988},{"id":"https://openalex.org/C2780833581","wikidata":"https://www.wikidata.org/wiki/Q2562556","display_name":"Ascending colon","level":2,"score":0.2524999976158142}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2025.pa4085","doi":"https://doi.org/10.1183/13993003.congress-2025.pa4085","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa4085","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pulmonary hypertension","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7154617539","https://openalex.org/W2000693477","https://openalex.org/W2328813010","https://openalex.org/W3137872656","https://openalex.org/W2019132480","https://openalex.org/W2162230936","https://openalex.org/W3096447447","https://openalex.org/W2912246118","https://openalex.org/W2780732982","https://openalex.org/W2393944889"],"abstract_inverted_index":{"Rho":[0],"kinase":[1],"(ROCK)":[2],"dysfunction":[3],"in":[4,60,86,172,186,208,226],"pulmonary":[5],"artery":[6],"hypertension":[7,13],"(PAH)":[8],"and":[9,23,42,65,78,88,101,114,124,136,149,174,182],"Interstitial":[10],"lung":[11],"disease-pulmonary":[12],"(ILD-PH)":[14],"contributes":[15],"to":[16,35,51,57,72,95,202],"the":[17,29,137,177,190],"pathogenesis":[18],"of":[19,40,104,116,131,139,179,192,197,220],"these":[20,216],"highly":[21],"morbid":[22],"ultimately":[24],"fatal":[25],"diseases.":[26],"ROC-101":[27,49,121,198],"is":[28],"first":[30],"orally":[31],"administered":[32,56],"ROCK1&2":[33,112,163],"inhibitor":[34,164],"be":[36],"considered":[37],"for":[38,159,169,176,189],"treatment":[39,178,191],"PAH":[41,230],"ILD-PH.":[43,232],"In":[44],"this":[45],"2-part,":[46],"first-in-human":[47],"study,":[48],"(up":[50],"40":[52],"mg":[53],"QD)":[54],"was":[55,81,122],"healthy":[58],"volunteers":[59],"single":[61,160],"(Part":[62,67],"A,":[63],"N=62)":[64],"multiple":[66],"B,":[68],"N=30)":[69],"ascending":[70],"doses":[71],"assess":[73],"safety,":[74],"tolerability,":[75],"PK,":[76],"PD,":[77],"biomarkers.":[79],"PK":[80],"characterized":[82],"by":[83,129],"dose-proportional":[84],"increases":[85,155],"Cmax":[87],"AUC.":[89],"Target":[90],"exposures":[91,200,207],"were":[92,147,156],"achieved":[93],"due":[94],"rapid":[96],"absorption":[97],"(Tmax,":[98],"1-3":[99],"h)":[100],"a":[102,209,221],"t1/2":[103],"12-14":[105],"hours.":[106],"PD":[107],"data":[108,217],"demonstrated":[109],"clinically":[110],"meaningful":[111],"inhibition":[113],"suppression":[115],"inflammatory":[117],"cytokines":[118],"(IL-17\u03b1,":[119],"IFN-\u03b3).":[120],"safe":[123],"well":[125],"tolerated,":[126],"as":[127],"evidenced":[128],"absence":[130,138],"hypotension":[132],"at":[133],"any":[134],"dose":[135,196],"SAEs":[140],"or":[141,231],"discontinuations.":[142],"The":[143,162,194],"most":[144],"common":[145],"TEAEs":[146],"headache":[148],"constipation":[150],"(4%-5%).":[151],"Clinically":[152],"significant":[153],"QTcF":[154],"not":[157],"observed":[158],"doses.":[161],"fasudil":[165,206],"has":[166,183],"been":[167,184],"approved":[168],">30":[170],"years":[171],"Japan":[173],"China":[175],"cerebral":[180],"vasospasm":[181],"evaluated":[185],"several":[187],"studies":[188],"PH.":[193],"top":[195],"yielded":[199],"up":[201],"25-fold":[203],"higher":[204],"than":[205],"historically":[210],"successful":[211],"investigator-initiated":[212],"PH":[213],"trial.":[214],"Together,":[215],"support":[218],"initiation":[219],"phase":[222],"2,":[223],"proof-of-concept":[224],"study":[225],"patients":[227],"who":[228],"have":[229]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2025-11-25T00:00:00"}